Effect of Inositol-phosphatase on Fc Receptor-mediated Phagocytosis of Macrophages

대식세포의 Fc 수용체를 통한 탐식에 미치는 Inositol-phosphatase의 영향

  • Kim, Jong-Hyun (Department of Obstetrics and Gynecology, Chonbuk National University Medical School)
  • 김종현 (전북대학교 의과대학 산부인과학교실)
  • Published : 2005.09.30

Abstract

Background: Fc receptor-mediated phagocytosis is a complex process involving the activation of kinases and phosphatases. FcgammaRIIB has been known to transduces inhibitory signals through an immunoreceptor tyrosine-based inhibitory motif (ITIM) in cytoplasmic domains. In this study, we examined the involvement of inositol-phosphatase in the Fc receptor-mediated phagocytosis. Methods: J774 cells were infected using vaccinia viral vector containing SH2 domain-containing inositol-phosphatase (SHIP) cDNA and stimulated with the sensitized sheep red blood cells. Results: Stimulation of J774 cells induced the tyrosine phosphorylation of SHIP which was maximal at 5 minutes. Phosphatidylinositol-3 (PI-3) kinase inhibitor (wortmannin) inhibits J774 cell phagocytosis of sensitized sheep red blood cells in a dose-dependent manner. Heterologious expression of SHIP in J774 cells inhibits phagocytosis of sensitized sheep red blood cells in a dose-dependency manner, but catalytically dead mutants of SHIP has no effect on phagocytosis. Conclusion: These results strongly suggest that the active signals mediated by PI-3 kinase are opposed by inhibitory signals through SHIP in the regulation of Fc receptor-mediated phagocytosis.

Keywords

References

  1. Takata M, Ono M, Hikida M, Ohmori H, Ravetch JV: Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379;346-349, 1996 https://doi.org/10.1038/379346a0
  2. Sylvestre DL, Ravetch JV: Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265; 1095-1098, 1994 https://doi.org/10.1126/science.8066448
  3. Lanier LL, Phillips JH: Evidence for three types of human cytotoxic lymphocyte. Immunol Today 7;132-134, 1986 https://doi.org/10.1016/0167-5699(86)90076-9
  4. Karakawa WW, Sutton A, Schneerson R, Karpas A, Vann WF: Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun 56;1090-1095, 1986
  5. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M: High affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367;183-186, 1994 https://doi.org/10.1038/367183a0
  6. Daeron M: Fc receptor biology. Annu Rev Immunol 15; 203-234, 1997 https://doi.org/10.1146/annurev.immunol.15.1.203
  7. Aderem A, Underhill DM: Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17;593-623, 1999 https://doi.org/10.1146/annurev.immunol.17.1.593
  8. Indik ZK, Park JG, Hunter S, Schrieber AD: The molecular dissection of Fc gamma receptor-mediated phagocytosis. Blood 86;4389-4399, 1995
  9. Kwiatkowska K, Sobota A: Signaling pathways in phagocytosis. Bioessays 21;422-431, 1999 https://doi.org/10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#
  10. Tonks NK, Neel BG: From form to function: signaling by protein tyrosine phosphatases. Cell 87;365-368, 1996 https://doi.org/10.1016/S0092-8674(00)81357-4
  11. Ravetch JV, Kinet J: Fc receptors. Annu Rev Immunol 9; 457-492, 1991 https://doi.org/10.1146/annurev.iy.09.040191.002325
  12. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV: FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76;519-529, 1994 https://doi.org/10.1016/0092-8674(94)90115-5
  13. Long EO: Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17;875-904, 1999 https://doi.org/10.1146/annurev.immunol.17.1.875
  14. Pumphrey N, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, Lord JM, Wakelam, MJO, Bird IN, Salmon M, Christopher DB: Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma-1 with PECAM-1/CD31. FEBS Lett 450;77-83, 1999 https://doi.org/10.1016/S0014-5793(99)00446-9
  15. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV: A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 368;70-73, 1994 https://doi.org/10.1038/368070a0
  16. Ono M, Bolland S, Tempst P, Ravetch JV: Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc gamma RIIB. Nature 383;263-266, 1996 https://doi.org/10.1038/383263a0
  17. Damen JE, Liu L, Rosten P, Humphires RK, Jefferson AB, Majerus PW, Krystal G: The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA 93;1689-1693, 1996
  18. Maresco DL, Osborne JM, Cooney D, Coggeshall KM, Anderson CL: The SH2-containing 5'-inositol phosphatase (SHIP) is tyrosine phosphorylated after Fc gamma receptor clustering in monocytes. J Immunol 162;6458-6465, 1999
  19. Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel S, Borowski A, Jirik F, Krystal G, Humphires RK: Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12;1610-1620, 1998 https://doi.org/10.1101/gad.12.11.1610
  20. Kim CH, Hangoc G, Cooper S, Helgason CD, Yew S, Humphries RK, Krystal G: Altered responsiveness to chemokines due to targeted disruption of SHIP. J Clin Invest 104;1751-1759, 1999 https://doi.org/10.1172/JCI7310
  21. Nakamura K, Brauweiler A, Cambier JC: Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)- 1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1- effector interactions and inhibitory functions. J Immunol 164;631-638, 2000 https://doi.org/10.4049/jimmunol.164.2.631
  22. Tridandapani S, Kelley T, Cooney D, Pradhan M, Coggeshall KM: Negative signaling in B cells: SHIP Grbs Shc. Immunol Today 18;424-427, 1997 https://doi.org/10.1016/S0167-5699(97)01112-2
  23. Newman PJ: Switched at births: a new family for PECAM-1. J Clin Invest 103;5-9, 1999 https://doi.org/10.1172/JCI5928